📰 Daniel Rabinowitz News
Daniel Rabinowitz News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Daniel Rabinowitz. Real-time updates on events, politics, business and more.
June 8, 2024
Haivision Systems Inc. (TSE:HAI – Get Free Report)’s share price shot up 2.2% during trading on Wednesday . The stock traded as high as C$4.69 and last traded at C$4.69. 59,581 shares traded hands during mid-day trading, an increase of 72% from the average session volume of 34,631 shares. The stock had previously closed at […]
May 23, 2024
Natera, Inc. (NASDAQ:NTRA – Get Free Report) has received a consensus rating of “Buy” from the fifteen brokerages that are presently covering the company, MarketBeat reports. Fifteen equities research analysts have rated the stock with a buy rating. The average twelve-month price objective among brokers that have issued a report on the stock in the […]
May 23, 2024
Annis Gardner Whiting Capital Advisors LLC grew its stake in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) by 29.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 3,230 shares of the medical research company’s stock after buying an additional 730 shares during the […]
May 20, 2024
StockNews.com upgraded shares of Natera (NASDAQ:NTRA – Free Report) from a sell rating to a hold rating in a report released on Friday. Several other equities research analysts also recently weighed in on the stock. Stephens reissued an overweight rating and issued a $78.00 target price on shares of Natera in a research report on […]
May 16, 2024
Inceptionr LLC acquired a new stake in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 4,907 shares of the medical research company’s stock, valued at approximately $307,000. Other institutional investors and hedge funds have also […]
May 3, 2024
Natera (NASDAQ:NTRA – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday. NTRA has been the subject of several other reports. Canaccord Genuity Group boosted their price objective on Natera from $87.00 to $100.00 and gave the stock […]
April 24, 2024
Several analysts have recently updated their ratings and price targets for Natera (NASDAQ: NTRA): 4/23/2024 – Natera was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating. 4/15/2024 – Natera had its price target raised by analysts at The Goldman Sachs Group, Inc. from $90.00 to $100.00. They now have a […]
April 18, 2024
Natera (NASDAQ:NTRA – Free Report) had its price objective hoisted by The Goldman Sachs Group from $90.00 to $100.00 in a research note released on Monday morning, Benzinga reports. The Goldman Sachs Group currently has a buy rating on the medical research company’s stock. NTRA has been the subject of several other reports. Craig Hallum […]
April 5, 2024
Natera, Inc. (NASDAQ:NTRA – Free Report) – Equities research analysts at Leerink Partnrs dropped their Q4 2024 earnings per share (EPS) estimates for shares of Natera in a research note issued on Monday, April 1st. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will post earnings per share of ($0.44) for […]
December 18, 2023
Guggenheim initiated coverage on shares of Natera (NASDAQ:NTRA – Free Report) in a research report sent to investors on Thursday morning, MarketBeat reports. The brokerage issued a buy rating and a $70.00 target price on the medical research company’s stock. Other equities analysts have also recently issued research reports about the company. Raymond James upgraded […]